U.S. biotech venture creator Flagship Pioneering is investing an initial £100 million (€120 million) to establish an AI-focused company-creation lab in London, marking the first expansion of its company-building model outside the United States.
ADVERTISEMENT
Tag Archive for: Venture Capital
Paris-based life sciences investor Sofinnova Partners has closed its second crossover fund at €725 million ($815 million), targeting around 15 biopharma and medtech companies, primarily in Europe. The fund is 63% larger than its predecessor and will support companies advancing through clinical development and toward commercialization.
Swiss venture capital investor Redalpine has closed its eighth fund at $250 million. Redalpine Capital VIII reached its hard cap and was oversubscribed, according to the firm. Less than 12 months passed between the first and final closings. In what remains a challenging fundraising environment for European venture capital firms, this represents a relatively quick closing.
Following Fresenius’ launch of a €200 million healthcare venture fund in July, we invited Thomas Thestrup, managing director of Fresenius Ventures, to share his perspective in the Autumn issue of European Biotechnology. His argument: Europe has the innovation and the corporate investment expertise to compete globally, but needs more capital from its own healthcare companies to prevent the value created by European science from moving elsewhere. Here’s what he had to say:
Dutch life sciences investor Forbion has raised €2.3 billion across two new funds to finance about 30 biotech companies, setting a fundraising record for the firm.
AI has transformed drug discovery, but the “AI biotech” label has become increasingly misleading. Kurma Partners proposes an investment framework that Âdistinguishes three fundamentally different models — each building a different asset, creating value in a Âdifferent way and requiring a different investment lens.
German healthcare group Fresenius has created a corporate venture capital unit that plans to invest more than €200 million in healthcare startups over the next five years.
Kos Biotechnology Partners has raised US$123m (€106m) for its inaugural global life sciences fund, marking a notable step for Greece’s still young biotechnology financing ecosystem.
Perceptic has raised a $12 million (€10.3 million) seed round to advance an AI operating system used by companies including CSL.
Isomorphic Labs has raised $2.1 billion (€1.8 billion) to further develop its artificial intelligence engine and advance drugs discovered using the platform.











